Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caring for patients with multimorbidity: moral distress and life satisfaction among doctors and nurses in Portugal.

PeerJ·2026
Same author

An Atypical Presentation of a Non-neural Granular Cell Tumor.

Cureus·2026
Same author

Fault-mediated magma propagation and triggered seismicity revealed by the 2022 São Jorge Azores unrest.

Nature communications·2026
Same author

Radiotherapy induces layer-specific molecular and ultrastructural alterations in triple-negative breast cancer spheroids.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Surgical Principles and Approaches to Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
Same author

A Prospective, International, Multicentre Registry of Patients Undergoing Segmental Mandibular Defect Reconstruction After Mandibular Resection for Tumours and Drug-Induced Osteonecrosis: A Study Protocol.

Craniomaxillofacial trauma & reconstruction·2026

Related Experiment Video

Updated: Jun 4, 2026

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
04:04

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection

Published on: August 15, 2025

Reoperative maxillofacial oncology.

Daniel Petrisor1, Rui Fernandes

  • 1Division of Oral and Maxillofacial Surgery, Department of Surgery, University of Florida, Jacksonville, FL 32209, USA.

Oral and Maxillofacial Surgery Clinics of North America
|January 29, 2011
PubMed
Summary

Oral squamous cell carcinoma (SCCA) frequently recurs after treatment, with most recurrences occurring within two years. Close patient follow-up is crucial for early detection and management of recurrent oral SCCA.

Related Experiment Videos

Last Updated: Jun 4, 2026

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
04:04

Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection

Published on: August 15, 2025

Area of Science:

  • Oncology
  • Head and Neck Surgery

Background:

  • Oral and oropharyngeal cancers affect approximately 36,000 individuals annually in the US.
  • Squamous cell carcinoma (SCCA) constitutes over 90% of these diagnoses.
  • Recurrence rates for oral SCCA range from 25% to 48% despite initial treatment.

Purpose of the Study:

  • To discuss the types of recurrence in oral SCCA.
  • To outline surveillance strategies for recurrent oral SCCA.
  • To review treatment options for recurrent oral SCCA.

Main Methods:

  • Literature review on oral SCCA recurrence.
  • Analysis of recurrence patterns and timelines.
  • Synthesis of current surveillance and treatment guidelines.

Main Results:

  • Most oral SCCA recurrences are observed within two years post-treatment.
  • Understanding recurrence types aids in tailored follow-up.
  • Timely detection through surveillance is key for effective management.

Conclusions:

  • Close follow-up is essential for patients treated for oral SCCA.
  • Effective surveillance protocols can improve outcomes for recurrent disease.
  • Management of recurrent oral SCCA requires a multidisciplinary approach.